Ketorolac disturbs proteasome functions and induces mitochondrial abnormality‐associated apoptosis
IUBMB Life · 2025
DOI: 10.1002/iub.2937 ↗Kurz gefasst
Fachartikel in der Zeitschrift IUBMB Life, 2025. Verfasst von Prashant Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India. Hauptthemen laut MEDLINE: Apoptosis, Proteasome Endopeptidase Complex, Mitochondria, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 105 Literaturangaben. Gefördert von: SERB, Science and Engineering Research Board.
Abstract (Originalsprache)
Non‐steroidal anti‐inflammatory drugs (NSAIDs) are recommended to treat moderate‐to‐severe pain. Previous studies suggest that NSAIDs can suppress cellular proliferation and elevate apoptosis in different cancer cells. Ketorolac is an NSAID and can reduce the cancer cells' viability. However, molecular mechanisms by which Ketorolac can induce apoptosis and be helpful as an anti‐tumor agent against carcinogenesis are unclear. Here, we observed treatment with Ketorolac disturbs proteasome functions, which induces aggregation of aberrant ubiquitinated proteins. Ketorolac exposure also induced the aggregation of expanded polyglutamine proteins, results cellular proteostasis disturbance. We found that the treatment of Ketorolac aggravates the accumulation of various cell cycle‐linked proteins, which results in pro‐apoptotic induction in cells. Ketorolac‐mediated proteasome disturbance leads to mitochondrial abnormalities. Finally, we have observed that Ketorolac treatment depolarized mitochondrial membrane potential, released cytochrome c into cytoplasm, and induced apoptosis in cells, which could be due to proteasome functional depletion. Perhaps more in‐depth research is required to understand the details of NSAID‐based anti‐proliferative molecular mechanisms that can elevate apoptosis in cancer cells and generate anti‐tumor potential with the combination of putative cancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular and Molecular Neurobiology Unit, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India.
- National Centre for Cell Science (NCCS), Pune, Maharashtra, India.
- Department of Biosciences and Biomedical Engineering, Indian Institute of Technology Indore, Indore, Madhya Pradesh, India.
- Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, Jodhpur, Rajasthan, India.
- Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, India.
ORCID-Profile: Amit Mishra
Förderung
- SERB
- Science and Engineering Research Board
Zitieren
APA
Kumar, P., Kinger, S., Dubey, A. R., Jagtap, Y. A., Choudhary, A., Karmakar, S., Lal, G., Kumar, A., Bhattacharyya, S., Poluri, K. M., & Mishra, A. (2025). Ketorolac disturbs proteasome functions and induces mitochondrial abnormality‐associated apoptosis. IUBMB Life. https://doi.org/10.1002/iub.2937
Vancouver
Kumar P, Kinger S, Dubey AR, Jagtap YA, Choudhary A, Karmakar S, et al. Ketorolac disturbs proteasome functions and induces mitochondrial abnormality‐associated apoptosis. IUBMB Life. 2025. doi:10.1002/iub.2937
BibTeX
@article{Kumar2025,
author = {Kumar, Prashant and Kinger, Sumit and Dubey, Ankur Rakesh and Jagtap, Yuvraj Anandrao and Choudhary, Akash and Karmakar, Surojit and Lal, Girdhari and Kumar, Amit and Bhattacharyya, Sudipta and Poluri, Krishna Mohan and Mishra, Amit},
title = {Ketorolac disturbs proteasome functions and induces mitochondrial abnormality‐associated apoptosis},
journal = {IUBMB Life},
year = {2025},
doi = {10.1002/iub.2937}
}
EUVIMED